Crude death rates due to metachronous out-of-field SPCs and RISPCs 50 and 50%, respectively. »
05/20/20

Overall interrater agreement between neuroradiologist and clinical neurosurgeons for T2-FLAIR mismatch sign significant. »
05/20/20

Smoking status important and modifiable baseline risk factor. »
05/24/20

Key factors of feasible treatment approach to CRF are coherent, cost effective integrative treatment program. »
05/24/20

Risk of death significantly increased following PE and major bleeding events. »
05/24/20

Cisplatin alone induced highest levels of ICD-associated DAMPs. »
05/26/20

CB-839 activity significantly compromised in 3D compared with 2D TNBC culture models. »
05/25/20

Patients with SMM had significantly higher prevalence of diabetes, hypertension and dyslipidemia. »
05/30/20

Significantly improved survival after disease progression correlated with clinical features at time of progression. »
02/05/20

Heavily pretreated mCRPC patient with AKT1 mutation experienced 50% decline in prostate-specific antigen with Akt inhibitor. »
01/20/20